The cancer cells identified as single cells or micrometastases (small clusters of 3–5 cancer cells) reveal a partial EMT program, using either αSMA‐Cre or Fsp1‐Cre as the mesenchymal phenotype tracking system. This evidence concerns the gene S100A4 and cancer.